Mechanistically, it was confirmed that tumor-derived TGF-β triggers CD39 and CD73 expression on circulating and tumor-infiltrating MDSCs via activation of mTOR/HIF-1α-signaling (70). This evidence concerns the gene NT5E and neoplasm.